INTRODUCTION
Spinal muscular atrophies (SMA types I, II and III) are characterized by progressive amyotrophic paralysis involving all skeletal muscle groups except the face and eye muscles (1) . Severe SMA is the most common recessively inherited genetic disease lethal to infants, and, in its milder forms, the second most common pediatric neuromuscular disorder (2) . The SMA locus was assigned to chromosome 5q11.2-13.3 (3, 4) . A gene located within the SMA critical region, termed the survival motor neuron (SMN) gene, has been reported more recently (5) . The SMN gene is contained in the more telomeric of two inverted duplicated elements of 500 kb in size. The centromeric cognate gene, termed c BCD541, has an open reading frame (ORF) potentially encoding a protein identical to that deduced by the SMN ORF. The two genes have later been renamed t SMN and c SMN (for telomeric and centromeric SMN, respectively). The telomeric gene, t SMN, was missing or interrupted in 226/229 SMA patients, and deleteriously mutated in the 3/229 remaining patients, providing strong evidence that this gene is an SMA-determining gene. Numerous later observations, including the identification of intragenic microrearrangements (6) and frameshift point mutations, have corroborated the idea that SMN is the essential gene responsible for the SMA phenotype (7) . The 1.5 kb SMN transcript(s) encode(s) a deduced protein of 294 amino acids with a predicted mol. wt of ∼32 kDa. The protein is ubiquitously expressed in humans, is conserved through mammalian species and shows no homology with any known protein (5) . A differentially spliced product, characterized by skipping of exon 7, accounts for ∼30-50% of the mature c SMN mRNA. Additional, differentially spliced SMN transcripts are characterized by 'skipping' of exon 5, or exon 5 and 7 together (8) . In a small percentage of controls, the c SMN gene is missing, with no apparent clinical consequences, raising questions about the functional role of c SMN in normal conditions. However, the absence of both t SMN and c SMN genes was never observed. Such a genotype is expected to result in an extremely severe form of SMA or in a non-viable fetus.
A second gene, termed NAIP, for neuronal apoptosis inhibitory protein, has been identified in the 5q13 region, and found to be deleted in ∼50% of SMA patients (9) . The etiopathogenetic role of this gene is more controversial; however, involvement of NAIP, and possibly other genes of the region, in the clinical expressivity of SMA cannot be excluded (2, 10) .
To understand the role of the SMN gene in the pathogenesis of SMA, we have characterized the distribution of the SMN transcript and protein in the central nervous system, by means of (i) light microscopy immunostaining of the SMN protein in the human cerebral cortex and in the brain and spinal cord of rat and monkey (Macaca nemestrina), and (ii) in situ hybridization of the SMN transcript in rat brain and spinal cord.
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RESULTS

Identification of a rat SMN cDNA
The cloning strategy is shown in Figure 1A . The full-length rat SMN cDNA ( Fig. 1B ; GenBank accession No. U75369) is 1243 bp in length. The corresponding transcript contains a 867 nucleotide ORF, spanning from nucleotide position 39, where the first AUG codon starts, to nucleotide 905, adjacent to an 'ochre' termination codon (UAA). A canonical AAUAAA polyadenylation signal is located 11 nucleotides upstream from a poly(A) tail. The attribution of the initiation codon to AUG 39-41 is supported by the presence of an upstream potential stop 'amber' codon (UAG) at nucleotides 30-32. If we consider AUG (39-41) as the physiological initiation site, the deduced protein consists of 289 amino acids. A second in-frame AUG codon is present in close proximity to the potential initiation site (nucleotides 45-47). We notice, however, that codons AUG (39-41), GCG (42-44) and AUG (45-47) are conserved between humans and rat, suggesting selective pressure against the loss of the corresponding amino acids (Met-Ala-Met) in the translation product in vivo. The attribution of the protein to the rat ortholog of human SMN is based on the high degree of amino acid identity between the two sequences (237/289, 82%), as shown in Figure 1C . Interestingly, both fragment length and sequence analyses of the several PCR DNA fragments obtained to construct the full-length cDNA contig (Fig. 1A ) gave no evidence in support of the existence of differentially spliced species of the SMN transcript in the rat liver. These results are similar to those recently reported in the mouse (11) , and suggest that the rat SMN is also not duplicated.
The deduced rat SMN protein (Fig. 1C) is a hydrophilic polypeptide with a calculated mol. wt of 31.193 kDa, similar to human SMN (mol. wt 31.853 kDa). The theoretical isoelectric point (pI) is 8.0.
In situ hybridization results
The results of in situ hybridization experiments are shown in Figure 2 . The SMN transcript was expressed diffusely in the gray matter of rat brain and spinal cord. In the cervical spinal cord, our rat-specific antisense riboprobe showed the highest hybridization signal in the ventral horn ( Fig. 2A) . A weaker signal was present in the dorsal horn, particularly in the more superficial laminae I-II-III ( Fig. 2A) . A specific signal was also detected in the spinal white matter, over (dendritic or axonal) projections emerging from the gray matter ( Fig. 2A) . In the cerebellum, the hybridization signal was confined to the granular layer and, less intensely, over the deep cerebellar nuclei. In the hippocampus, it was particularly intense in the granule cell layer of the dentate gyrus, and over the pyramidal cell layer of the CA1, CA2 and CA3 regions (Fig. 2B) . In the neocortex, the hybridization signal was more intense in the infragranular layers, consistent with the immunohistochemical data (see below). No hybridization signal was obtained in all considered areas by using a sense riboprobe (not shown).
Characterization of anti SMN-specific antibodies
The two rabbit polyclonal antibodies #1136 and #1137 were characterized by in vitro and in vivo immunoprecipitation experiments, Western blot analyzis and in situ adsorption tests.
After immunoprecipitation of the [ 35 S]-radiolabeled in vitro translation products of human and rat SMN cDNAs, a single protein species was immunoprecipitated specifically by both antibodies (Fig. 3A) . Its electrophoretic mobility corresponded to a mol. wt of ∼35 kDa, identical to the major in vitro translation product of either rat or human SMN cDNAs. By contrast, no immunoprecipitation product was obtained using an antibody directed against an unrelated antigen (i.e. the human mitochondrial single-stranded DNA-binding protein). In vivo immunoprecipitation by either #1136 or #1137 antibody of total [ 35 S]methionine-labeled COS-7 proteins again revealed a single band of ∼35 kDa. The size of this band corresponded to that of the in vitro human SMN translation product, immunoprecipitated by the same antibodies (Fig. 3B) . By contrast, no specific band was immunoprecipitated by the corresponding pre-immune antisera.
A single, strongly reactive band of ∼35 kDa was immunodetected by antibody #1137 in Western blot experiments on HeLa, human lymphoblastoid, and monkey COS-7 cell lysates (Fig. 3C) . The immunostaining was abolished completely by incubating the antibody with the corresponding antigenic peptide. Identical results were obtained using antibody #1136 (not shown).
Finally, the staining obtained with antibody #1137 on thin cryostat sections from monkey and rat spinal cord was compared with that obtained with the antisera pre-incubated with an excess of the antigenic peptide. In contrast to the finely granular cytoplasmic labeling of lamina IX motor neurons (Fig. 4A) , no reaction was detected by using the immunoadsorbed antibody (Fig. 4B) . Identical results were obtained with the #1136 antibody (not shown).
Immunocytochemical results
Specific immunoreactivity was confined mainly to the cytoplasm of neurons in the structures examined in the brain and spinal cord of rat and monkey, and in the human prefrontal cortex. A low intensity staining was observed occasionally in the white matter, possibly due to SMN expression in glial cells. The results obtained using the #1137 IgG fraction are described below. Identical results were obtained using the #1136 antiserum (not shown).
Spinal cord. In the thoracic spinal cord of both monkeys and rats, the motor neurons in lamina IX were labeled intensely (Fig. 5C) ; the fine granular reaction product was distributed in the perikarya and proximal dendrites, and outlined the unlabeled nuclei ( Fig. 5B and D). Moreover, different intensity of motor neuron staining was evident in thin cryostat sections: strongly labeled neurons were intermingled with more weakly or virtually unlabeled cells (Fig.  5F ). The lamina IX neuropil was characterized by labeled dot-like or thread-like structures, possibly representing cross-sectioned dendrites or axons, also extending into the ventral white matter ( Fig. 5D ). Outside lamina IX, the sympathetic preganglionic neurons of the thoracic intermediolateral nucleus were intensely immunoreactive ( Fig. 5A and B) . Strongly labeled neurons were also present more medially in the Clarke's column, i.e. the origin of the dorsal spinocerebellar tract (Fig. 5A ). In the dorsal horn, sparse labeled neurons were present in lamina I; the neuropil in laminae I, II and III was weakly immunoreactive (Fig. 5A ). Consistent with this finding, SMN immunoreactivity was detected in neurons of the dorsal root ganglia that innervate the superficial laminae of the spinal dorsal horn. In the rat cervical spinal cord, in addition to the intense staining of motor neurons, strong immunoreactivity was present in the lateral spinal nucleus and lateral lamina V cells, i.e. somatosensory neurons projecting to supraspinal centers (Fig. 5E ).
The staining obtained in adult animals was compared with the SMN immunoreactivity in the cervical spinal cord of developing rats. At postnatal day 1, the labeling of motor neurons was more intense and more selective than that observed in adult rats ( Fig.  6A and B): outside the motor neuron compartment, only a few neurons in the lateral spinal nucleus were very lightly stained. At postnatal day 15, more widespread SMN immunoreactivity was observed, similar to, but more intense than, that obtained in adult animals (not shown).
Brain areas. In the lower brainstem, intense neuronal staining was detected in the somatic and visceral motor neurons (i.e. the ambiguus, dorsal vagal and hypoglossal nuclei Fig. 7A ). However, it was also evident outside motor structures, such as the inferior olive, reticular formation and lateral cuneate nucleus (Fig. 7B) , i.e. the origin of the cuneocerebellar tract. The major fiber tracts, such as the hypoglossal nerve and the pyramidal and solitary tracts, were unlabeled. In the rat upper brainstem, neurons were labeled in all motor nuclei, i.e. the facial, motor trigeminal and ocular motor nuclei. Some large neurons within the red nucleus were also intensely stained. SMN immunoreactivity was also present outside motor structures, such as in the dorsal cochlear and lateral vestibular nuclei; it was particularly intense in the large primary sensory neurons of the trigeminal mesencephalic nucleus, and in neurons of the pontine precerebellar nuclei.
In the cerebellum, the Purkinje cells were mostly unstained, and their somata frequently were outlined by the surrounding labeled neuropil. The molecular and granular layers were characterized by faint neuropil staining, whereas the deep cerebellar nuclei were intensely SMN immunoreactive (Fig. 7C ). In the basal ganglia, the low SMN immunoreactivity of the caudate and putamen nuclei contrasted with a specific neuronal immunostaining of the basal nucleus of Meynert and globus pallidus. In the rat thalamus, the neurons of the reticular nucleus were clearly SMN immunoreactive; some neurons were also stained, although less intensely, in the anterior and midline nuclei. In the hippocampus, the pyramidal neurons of the Cornu Ammonis (CA) and many interneurons in the alveus and stratum oriens were clearly labeled. In the dentate gyrus, a densely immunopositive neuropil outlined the cell bodies of the granule cells; the hilar interneurons were moderately labeled (Fig. 7D) .
In the rat neocortex, and in monkey temporal and occipital cortices, the SMN immunostaining was confined mainly to the deep cortical layers. This gradient of labeling was more evident in the human prefrontal cortex, where numerous large pyramidal neurons of layer V were stained intensely ( Fig. 8A and B) . The fine granular immunoreactivity was confined to the cytoplasm of the perikarya, and apical and basal dendrites (Fig. 8B ). Pyramidal and multipolar neurons were also stained intensely in layer VI, particularly close to the white matter border (Fig. 8A) . The immunoreactivity was less intense in the supragranular layers: some small pyramidal neurons of layers II and III were labeled, whereas the fibers of layer I were unstained.
Cultured cells.
Since a recent report demonstrated the presence of the SMN protein in the nuclei of cultured HeLa cells (12), we tested our SMN antibodies in non-neuronal cultured cells. In COS-7 and HeLa cells, a fine granular fluorescence was evident in the cytoplasm (Fig. 9A and B) . However, a few discrete, intensely immunofluorescent, dot-like structures were also detected in the nuclei of both cell types. The cytoplasmic staining was more prominent in COS-7 cells (Fig. 9A) , whereas the dot-like nuclear structures were more numerous and intensely labeled in HeLa cells (Fig. 9B) . A diffuse, very low intensity 'background' signal was present in control experiments performed by omitting the primary antibody or by using the pre-immune serum (not shown).
DISCUSSION
Using both immunocytochemistry and in situ hybridization techniques, we worked out a neuroanatomical mapping of the SMN transcript and protein in the CNS of humans, monkey and rat.
Antibody specificity
The specificity and species cross-reactivity of our antibodies were demonstrated by the following evidence. First, the antibodies were able to immunoprecipitate the in vitro translation products of both rat and human SMN cDNAs. Second, in vivo immunoprecipitation and immunoblot experiments demonstrated that antibodies specifically and consistently detected a single protein band, whose size was identical to that of the in vitro translation products of human and rat SMN cDNAs. Third, the immunostaining was consistently and completely blocked by pre-incubation of both antibodies with an excess of the antigenic peptide. This was demonstrated by in vivo immunoprecipitation and immunoblot experiments on monkey-and human-derived cellular lines, as well as by immunoadsorption experiments on thin cryostat sections from rat and monkey spinal cord. Fourth, our immunofluorescence results on cultured cellular lines were very similar to those recently obtained by Liu and Dreyfuss with monoclonal antibodies directed against a purified recombinant SMN protein (12) . The existence of specific cross-reactivity was supported further by the similarity of the immunocytochemistry results obtained in the three different mammalian species. Taken together, these data indicate that the immunoreactivity mapping reported here corresponds to the cellular and subcellular distribution of the SMN protein. 
CNS regional distribution of the SMN transcript and protein
Both the immunocytochemistry and in situ hybridization data reported here demonstrated a widespread expression of the SMN gene in the mammalian CNS. However, in situ hybridization revealed that the SMN gene was expressed unevenly within several brain areas, such as the neocortex, hippocampus, cerebellum and spinal cord. In the latter, the in situ hybridization signal was intense in the ventral horn, and virtually absent in the superficial laminae of the dorsal horn. The immunocytochemistry data confirmed and extended the in situ hybridization findings, in demonstrating that (i) the SMN protein was localized predominantly in the cytoplasm of neurons of all three species; (ii) the expression of the SMN protein was selective, as it was particularly abundant in specific neuronal cell populations, such as in layer V pyramidal neurons of the neocortex, the pallidal neurons in the basal ganglia, the neurons of the deep cerebellar nuclei and the motor neurons of the brainstem and spinal cord. These findings offer for the first time an anatomical basis to support the pathogenetic role of the SMN gene in the neuronal degeneration associated with SMA.
The neuropathological hallmark of all clinical types of SMA is an early and progressive degeneration of the motor neurons in spinal cord and lower brainstem (13) . The predominant SMN immunoreactivity reported here in the lower somatic motor neurons indicate that the SMN protein is expressed particularly in the very cells whose specific degeneration and death are responsible for the SMA phenotypes. Moreover, the high and selective SMN immunoreactivity in motor neurons of newborn rats suggests that SMN expression is developmentally regulated and may be involved in the ontogenesis of motor neurons. To address this hypothesis further, studies on the CNS of rat embryos are currently underway. Finally, our observations indicate that SMN protein expression can vary widely among individual motor neurons. This differential expression could account for the survival and functional integrity of a substantial fraction of motor neurons in the milder clinical forms of SMA, as indicated by neurophysiological studies (14) .
In addition to somatic motor neurons, specific SMN immunoreactivity was detected in other neuronal cell populations. Although the neuropathological studies on SMA have been performed before the molecular diagnosis of SMA was possible, they suggested a more diffuse CNS degeneration (15) (16) (17) involving for instance neurons of the Clarke's column and dorsal root ganglia (18) (19) (20) (21) (22) . The neuropathological involvement of neurons other than lower motor neurons was confirmed more recently in a severely affected SMA type I patient in whom the clinical diagnosis was confirmed by molecular analysis (23) . Consistent with these data, strong expression of the SMN protein was revealed in the same neuronal cell subpopulations by our immunocytochemistry experiments.
Subcellular localization of the SMN protein: nuclear versus cytoplasmic
Monoclonal anti-SMN antibodies recently were reported specifically to label newly identified dot-like structures in the nuclei of cultured HeLa cells (12) . These nuclear structures, dubbed GEMS (for gemini of coiled bodies), were proposed to be related to RNA metabolism, and possibly associated with the classical 'coiled bodies' of early cytologists (24) . In the same report, however, a fine granular immunoreactivity was described in the cytoplasm of HeLa cells, and stronger cytoplasmic labeling was detected in 3T3 mouse fibroblasts. In addition, variability of the nuclear versus cytoplasmic distribution of the SMN protein was observed in relation to different stages of the cell cycle and under the effect of transcription inhibitors. These data suggest that the organization of GEMS, as well as the distribution of SMN, can change dramatically in relation to the cellular metabolic state, possibly in response to the levels of RNA metabolism.
Our immunostaining results in cell cultures were virtually identical to those of Liu and Dreyfuss. However, our immunocytochemistry data indicate that the subcellular localization of the SMN protein in postnatal, non-dividing, fully differentiated neurons is mainly cytoplasmic. Thus, the nuclear localization is neither exclusive nor predominant in neurons and other cell types. The physiological role of SMN is clearly more complex. It is possible that different isoforms of the SMN protein are distributed in different subcellular compartments. Moreover, the protein may retain different, spatially separated functions, depending on factors such as cell type, cell cycle, specialization of tissue, age and maturation of the organism, etc. Examples of functionally related nucleus-cytoplasm trafficking are well known in mammalian cells.
For instance, the steroid hormone receptor has been shown to diffuse into the cytoplasm from which it is constantly and actively transported back to the nucleus (25) . Ultrastructural data on SMN protein expression in both cultured cells and in vivo nervous tissue, including motor neurons, may help to shed light on the intracellular trafficking and function of the SMN gene product.
SMN and SMA
In spite of the discovery of SMN, and possibly NAIP, that are clearly involved in the etiology of SMA, the cellular pathogenesis of the disease is still poorly understood. One of the most intriguing problems is the fact that expression of SMN (as well as NAIP) is not completely abolished in SMA patients, since the centromeric copy of the SMN gene seems to remain functionally active. This can account for the presence of immunodetectable SMN protein in SMA patients carrying large-scale deletions of the t SMN gene (26) . However, the differential splicing of a proportion of c SMN transcript, that should give rise to a 'truncated' protein, suggests that there is an important functional difference between c SMN and t SMN products. Another puzzling question is that SMN is likely to play a widespread and crucial role in all tissues of the organism. This is similar to other genes responsible for genetically determined neurodegenerative disorders, such as Huntington's disease (27, 28) and spino-cerebellar atrophy type I (29) .
Our findings show that the SMN protein is expressed abundantly and specifically from an early age in spinal and brainstem motor neurons. Qualitative and/or quantitative abnormalities of the SMN protein could affect the function, and eventually the very existence, of these neurons. A gene dosage effect has indeed been suggested by Lefebvre et al. , who showed that the amount of immunoreactive SMN protein is clearly decreased, but not absent, in SMA patients harboring deletions of the t SMN gene, compared with age-matched controls (26) . However, our data revealed that a strong expression of the SMN protein was also present in neurons apparently not affected in SMA, such as the spinal preganglionic sympathetic neurons and the neocortical pyramidal neurons. One possibility is that motor neurons are exquisitely dependent upon SMN expression, requiring high amounts of SMN protein to survive. When two of the four available SMN alleles are missing or mutated, as occurs in SMA patients, the amount of SMN could drop below the threshold critical for the survival of motor neurons, but it might still be compatible with the survival of other less susceptible cell types in the CNS or other tissues. This hypothesis is supported by the recent report of an SMA patient in whom a homozygous deletion of the t SMN gene was associated with a single copy of a chimeric c SMN gene (23) . This patient had a congenital type I SMA, characterized by an extremely severe and widespread neurodegeneration, extending far beyond the motor neuron compartment.
MATERIALS AND METHODS
Rat SMN cDNA: cloning strategy
The cloning strategy used to identify the rat SMN ortholog was based on a series of PCR reactions (Fig. 1A) . The RACE (rapid amplification of cDNA ends)-ready cDNA kit r (Clontech, Palo Alto, CA) was used as a source of rat liver cDNA in all the experiments. Thirty five cycles were performed in all the PCR reactions; conditions for each cycle were as follows: denaturation at 94_C for 1 min, annealing at 50_C for 1 min, extension at 72_C for 1 min.
A first PCR amplification was carried out using the 5′ 'anchor' primer of the RACE-ready cDNA kit r and an antisense primer spanning the reverse-complementary sequence of the human SMN cDNA corresponding to nucleotides 859-891. No visible DNA fragments were obtained in this reaction. However, a second, 'hemi-nested' PCR amplification was then carried out on the first PCR product, using an internal sense primer spanning nucleotides 490-519 of the human SMN cDNA sequence, together with the same antisense primer used in the first reaction. A single DNA fragment of ∼400 bp was obtained by this amplification. Sequence analysis demonstrated that the fragment was a 431 bp partial-length rat ortholog of the human SMN cDNA. The sequence information obtained from this PCR fragment was exploited to design several rat-specific primers. These primers were used in a series of 'hemi-nested' PCR reactions on rat liver cDNA to construct a contig of DNA fragments encompassing most of the full-length SMN cDNA (Fig. 1A) . The 5′ and 3′ ends of the cDNA were then obtained by RACE, using the rat-specific primers together with the 3′ and 5′ 'anchor' primers of the RACE kit. Finally, a single PCR fragment encompassing the full-length cDNA was PCR-amplified using 5′-and 3′-specific primers, subcloned into the pMOS-1 plasmid r (Pharmacia, Uppsala, Sweden) and sequenced in an automated 373-A sequencer (Applied Biosystems, Foster City, CA) using the Perkin-Elmer dye-terminator sequencing kit r . Comparison with the human SMN cDNA was carried out using the Geneworks r software package v. 4.2.5 (Intelligenetics, Mountain View, CA).
Generation and characterization of anti-SMN antibodies
Production of human SMN-specific rabbit polyclonal antibodies. An oligopeptide of 15 amino acid residues corresponding to the N-terminus of the deduced human SMN protein sequence (MAMSSGGSGGGVPEQ) was synthesized by Neosystem Co. (Strasbourg, France). The 15 amino acid peptide, serving as an antigen, was coupled to keyhole limpet hemocyanin, serving as an immunogenic carrier, via a C-terminal tripeptide (Arg-Lys-Tyr). The Arg-Lys dipeptide was added to increase the hydrophilicity of the antigenic peptide, and the Tyr residue to promote glutaraldehyde-mediated coupling to the carrier. Two rabbits were first immunized with an injection of the antigen-carrier conjugate, followed by two subsequent boosts, one every month. The two antisera, called #1136 and #1137, were collected from a final bleeding. The IgG fraction of antiserum #1137 was then purified by immunoaffinity using the Gammabind r kit (Pharmacia).
Immunoprecipitation of in vitro translation products. Human and rat SMN cDNAs were PCR-amplified using a sense primer containing a 5′ extension corresponding to the SP6 promoter. The PCR products were then transcribed in vitro using the SP6 RNA polymerase of the SP6/T7 Transcription kit r (BoehringerMannheim, Germany). Transcripts were in vitro translated in the presence of [ 35 S]methionine using the Rabbit Reticulocyte Lysate System kit r (Promega, Madison, WI). The translation products were incubated overnight with 10 µl of antibody at 4_C. Incubation with 100 µl of Staphylococcus aureus lysate (Staph A, 10% w/v) (Gibco-BRL, Life Technologies) for 30 min at room temperature was followed by centrifugation at 4000 g for 5 min. Washed pellet was electrophoresed through a 12% SDS-PAGE minigel. After fixation in 10% acetic acid, 25% isopropanol, the gel was washed for 15 min in Amplify r (Amersham, Little Chalfont, UK), dried and autoradiographed overnight onto Hyperfilm r (Amersham).
Immunoprecipitation in 35 S-radiolabeled COS-7 cells.
Approximately 2×10 6 COS-7 cells were maintained for 2 h in a medium lacking methionine and then exposed to 100 µCi/plate of [ 35 S]methionine for an additional 2 h. Cells were washed three times in phosphate-buffered saline (PBS) with 2% 'cold' methionine and lysed in 1 ml of 150 mM NaCl, 10 mM EDTA (pH 8.0), 2% cold methionine, 0.25% SDS, 0.5% Triton X-100 in the presence of a mixture of protease inhibitors. After sonication and pre-incubation with 100 µl/sample of Staph A, the lysate was centrifuged for 30 min at 18 000 g. The supernatant was immunoprecipitated, electrophoresed and autoradiographed as above.
Western blot analysis. HeLa cells, human normal lymphoblastoid cells and monkey tumoral kidney COS-7 cells were used for immunoblot analysis. Approximately 2×10 6 cells were trypsinized, pelleted, sonicated, solubilized with 0.25% SDS in the presence of a mixture of protease inhibitors and centrifuged at 10 000 g for 15 min at 4_C. SDS-PAGE of ∼50 µg of protein/lane was performed as above. The gel was then electroblotted for 45 min onto a nitrocellulose filter. The latter was incubated with 5% non-fat milk in Tris-buffered saline (TBS), 0.1% Tween-20 (MTT) for 45 min at room temperature followed by incubation for 1 h at room temperature with a 1/500 dilution of primary antibody or pre-immune serum in MTT. In one set of experiments, the primary antibody was pre-incubated overnight at 4_C with 1.8 µg/ml (5 µM) of the antigen-carrier conjugate (immunoadsorption test). After four washings in TBS, 0.1% Tween-20 (5 min/each), the filter was incubated for 1 h at room temperature with a 1/1500 dilution of biotinylated donkey anti-rabbit IgG in MTT. After four washings as above, the filter was incubated with a 1/3000 dilution of horseradish peroxidase-coupled streptavidin for 1 h at room temperature. After four additional washings, the peroxidase reaction was revealed by autoradiography using the chemiluminescence ECL kit r (Amersham).
In situ adsorption test. The diluted antibodies (1/10 000 in PBS-1% normal goat serum (NGS) and 0.2% Triton-X 100) were preincubated overnight with 5 and 10 µM (1.8 and 3.6 µg/ml) free antigenic peptide before use. Both control and immunoadsorbed antibodies were applied as 30-40 µl drops onto thin cryostat sections from rat and monkey spinal cord at 4_C in a humid chamber. Sections were then parallel processed with a standard immunocytochemical procedure (see below).
Morphological studies
Animal and human tissue samples. Eight adult (aged 2 months), two developing Sprague-Dawley male rats (postnatal day 1 and 15, respectively) and three Macaca nemestrina male monkeys (aged 7-11 years) were used in the immunohistochemical experiments. Six adult Sprague-Dawley male rats (aged 2 months) were employed to collect the in situ hybridization data. Monkey tissues were obtained as a by-product from the Physiology Department of the Parma State University School of Medicine; the thoracic spinal cord and dorsal root ganglia, the lower brainstem, cerebellum, basal ganglia and the temporal and occipital cortices were available for the anatomical analysis. Animals were deeply anesthetized with either 1 mg/100 g of body weight of 4% chloral hydrate (rats), or 4 mg/100 g of body weight of sodium pentobarbital (monkeys). Animals were then perfused with either 1% paraformaldehyde followed by 4% paraformaldehyde (rats), or with saline followed by 3.5% paraformaldehyde in 0.1 M phosphate buffer pH 7.4 (monkeys). Human prefrontal cortical samples were obtained from surgical specimens removed for strictly therapeutical reasons at the National Neurological Institute 'C. Besta', and immediately fixed by immersion in 4% paraformaldehyde for several days.
In situ hybridization on rat CNS tissues. The region of rat SMN cDNA encompassing bases 306-506, corresponding to exon 3 of the human ortholog, was PCR amplified with two synthetic oligonucleotides, each containing a 5′ extension corresponding to the promoter sequences of Sp6 (sense primer) or T7 (antisense primer) RNA polymerases. The PCR fragments were then used as templates for the synthesis of 35 S-radiolabeled sense or antisense RNA probes (riboprobes), by incubation for 1 h at 37_C with 500 µM ATP, CTP and GTP, 1× transcription buffer, 10 µM dithiothreitol (DTT), 40 U/µl RNase, 12.5 µCi/µl [ 35 S]UTP and T7 (for antisense probes) or SP6 (for sense probes) RNA polymerases. The DNA templates were then digested with 10 U/µl DNase, and the riboprobes purified with phenol-chloroform (1:1, v/v), and precipitated with 7 M ammonium acetate and cold 100% ethanol. After precipitation, riboprobes were dried and resuspended in 10 µl diethylpyrocarbonate-treated double-distilled H 2 O.
Brain and spinal cord cryostat sections (stored at -80_C) were dried at room temperature, re-hydrated in 4× 0.1 M PBS and 0.2% Triton X-100, rinsed in PBS and fixed in 4% paraformaldehyde in PBS. Sections were then treated with proteinase K (10 g/ml), rinsed in PBS, acetylated in 0.1 M triethanolamine-acetic anhydride, washed in 0.2 M NaCl-Na citrate (2× SSC), and serially de-hydrated in 70, 80, 95 and 100% ethanols. The 35 S-labeled riboprobes were dissolved in hybridization buffer containing 4× SSC, 50% deionized formamide, 10% dextran sulfate, 1× Denhardt's solution, 1 mg/ml denatured salmon sperm DNA and 1 mM DTT. Hybridization was performed overnight at 58_C, under glass coverslips in a humid chamber. Sections were then washed at a final stringency of 0.1× SSC at 60 or 65_C, and exposed to β-max films at room temperature for ∼1 week. In order to obtain cellular resolution, sections were then dipped in Kodak NTB2 emulsion, exposed in the dark at 4_C for 3-8 weeks, developed in Kodak D-19, fixed in Kodak UNIFIXER, covered with DPX, and finally examined in a dark field with a Leitz microscope. Adjacent series of sections were counterstained with 0.1% thionin for cytoarchitectonic analysis (30) .
Immunohistochemistry. After perfusion or post-fixation, the specimen slabs were (i) cut with a vibratome in 40 µm thick coronal sections; or (ii) immersed in step-wise increasingly concentrated sucrose solutions (10, 20, 30%), snap-frozen in liquid nitrogencooled isopentane (-40_C), cut in 10-12 µm coronal sections with a cryostat, thaw-mounted on gelatin-coated slides and stored at -80_C until processed. Sections were pre-treated with 1% H 2 O 2 in PBS to remove the endogenous peroxidase activity, rinsed in PBS and incubated with 10% NGS-0.2% Triton X-100 for 60 min to mask non-specific adsorption sites. Sections were then incubated overnight at 4_C with either the anti-SMN antibodies (diluted 1/10 000 in PBS-1% NGS and 0.2% Triton X-100), with the pre-immune sera (used at the same dilution) for control experiments or with anti-SMN antibodies pre-incubated with an excess of SMN peptide for the in situ absorption test experiments. After rinsing for 1 h in PBS, the sections were incubated with a 1:200 dilution of biotinylated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) for 75 min, rinsed for 1 h in PBS and then incubated with the ABC complex (Vector) for 75 min. Peroxidase staining was obtained by incubating the sections in 0.075% DAB and 0.002% H 2 O 2 in 50 mM Tris buffer at pH 7.6. Sections were mounted on gelatin-coated glass slides, air dried, dehydrated and coverslipped with DPX. The sections adjacent to the immunoreacted ones were counterstained with 0.1% thionin for cytoarchitectonic analysis (30, 31) .
Immunofluorescence on COS-7 and HeLa cells. COS-7 cells and
HeLa cells were grown on glass coverslips. After two washes in PBS, cells were fixed in 50 and 100% methanol (1 min each), air-dried, pre-incubated with 10% NGS in PBS for 30 min and incubated with a 1/100 dilution of anti-SMN antibodies for 90 min. After several rinses in PBS, cells were incubated with a 1/500 dilution of a biotinylated goat anti-rabbit IgG (Vector) for 60 min, rinsed in PBS, incubated with a 1/500 dilution of rhodamine-avidin D (Vector) for 60 min, rinsed again in PBS and covered with a glycerol mountant.
